Bio-Techne (TECH) Non Operating Income (2009 - 2026)
Bio-Techne (TECH) posted quarterly Non Operating Income of -$4.3 million for Q1 2026, down 883.87% year-over-year from $544732.5 in Q1 2025, and down 16.13% quarter-over-quarter from -$3.7 million in Q4 2025.
Bio-Techne (TECH) Non Operating Income (2009 - 2026) Analysis & Trends
Bio-Techne's Non Operating Income history runs 18 years deep, the most recent figure standing at -$4.3 million for Q1 2026.
- In Q1 2026, Non Operating Income fell 883.87% year-over-year to -$4.3 million; the TTM figure through Mar 2026 stood at -$6.6 million (up 26.15% YoY), while the FY2025 annual figure was -$3.8 million, up 81.94% from the prior year.
- Non Operating Income for Q1 2026 stood at -$4.3 million, down from -$3.7 million in the prior quarter.
- The five-year high for Non Operating Income was $47.4 million in Q3 2022, with the low at -$21.7 million in Q1 2022.
- The 5-year median for Non Operating Income is -$3.7 million (2025), against an average of -$934470.6.
- The sharpest annual moves came in 2022 and 2024: Non Operating Income soared 1039.13% in 2022, then sank 39326.67% in 2024.
- Bio-Techne's Non Operating Income stood at -$1.5 million in 2022, then plunged by 215.8% to -$4.6 million in 2023, then climbed by 1.6% to -$4.5 million in 2024, then increased by 19.06% to -$3.7 million in 2025, then retreated by 16.13% to -$4.3 million in 2026.
- Business Quant data shows TECH's Non Operating Income at -$4.3 million in Q1 2026, -$3.7 million in Q4 2025, and $333000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 234.30 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -139.24 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 12.40 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -51.63 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -53.64 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Bio-Techne | 11.33 Bn | 11.12 Bn | 208.29 Mn | -4.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.27 Mn |
| Dec 31, 2025 | -3.68 Mn |
| Sep 30, 2025 | 333,000.00 |
| Jun 30, 2025 | 1.00 Mn |
| Mar 31, 2025 | -434,000.00 |
| Dec 31, 2024 | -4.54 Mn |
| Sep 30, 2024 | 184,000.00 |
| Jun 30, 2024 | -4.16 Mn |
| Mar 31, 2024 | -5.91 Mn |
| Dec 31, 2023 | -4.62 Mn |
| Sep 30, 2023 | -6.30 Mn |
| Jun 30, 2023 | -6.21 Mn |
| Mar 31, 2023 | -15,000.00 |
| Dec 31, 2022 | -1.46 Mn |
| Sep 30, 2022 | 47.40 Mn |
| Jun 30, 2022 | -1.52 Mn |
| Mar 31, 2022 | -21.68 Mn |
| Dec 31, 2021 | 23.83 Mn |
| Sep 30, 2021 | 4.16 Mn |
| Jun 30, 2021 | -61.47 Mn |